AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 295: G581-G590, 2008. First published July 17, 2008; doi:10.1152/ajpgi.90311.2008
0193-1857/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/G581    most recent
ajpgi.90311.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Floer, M.
Right arrow Articles by Rafiee, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floer, M.
Right arrow Articles by Rafiee, P.

INFLAMMATION/IMMUNITY/MEDIATORS

Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation

Martin Floer ,1,4,* David G. Binion,1,* Victoria M. Nelson,1 Sharon Manley,1 Michael Wellner,2 Saba Sadeghi,2 Behnaz Behmaram,3 Chloe Sewell,1 Mary F. Otterson,2 Torsten Kucharzik,4 and Parvaneh Rafiee2

Departments of 1Medicine, 2Surgery, and 3Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin; 4Department of Medicine B, University Hospital Muenster, Germany

Submitted 29 April 2008 ; accepted in final form 16 July 2008

Tissue remodeling and mesenchymal cell accumulation accompanies chronic inflammatory disorders involving joints, lung, vasculature, and bowel. Chronic inflammation may alter DNA-mismatch repair (MMR) systems in mesenchymal cells, but is not defined in Crohn's disease (CD) and its associated intestinal remodeling and stricture formation. We determined whether DNA-MMR alteration plays a role in the pathogenesis of CD tissue remodeling. Control and CD bowel tissues were used to generate primary cultures of muscularis mucosa myofibroblasts, which were assessed directly or following stimulation with TNF-{alpha}/LPS or H2O2. MutS homolog (MSH)2, MSH3, and MSH6 expression in tissues and myofibroblasts was determined. Immunohistochemical staining revealed an increased expression of MSH2 in CD muscularis mucosa and submucosal tissues compared with controls or uninvolved CD tissue, and MSH2 expression was increased in CD myofibroblasts compared with control cells. TNF-{alpha}/LPS and H2O2 further enhanced MSH2 expression in both control and CD cells, which were decreased by simvastatin. There were no significant changes in MSH3 and MSH6 expression. Proliferating cell nuclear antigen and Ki67 staining of CD tissue revealed increased proliferation in the muscularis mucosa and submucosa of chronically inflamed tissues, and enhanced proliferation was seen in CD myofibroblasts compared with controls. Simvastatin reversed the effects of inflammatory stress on the DNA-MMR and inhibited proliferation of control and CD myofibroblasts. Gene silencing with MSH2 siRNA selectively decreased CD myofibroblast proliferation. These data demonstrate a potential role for MSH2 in the pathogenesis of nonneoplastic mesenchymal cell accumulation and intestinal remodeling in CD chronic inflammation.

ulcerative colitis; simvastatin; MSH2 siRNA


Address for reprint requests and other correspondence: P. Rafiee, Dept. of Surgery, Medical Coll. of WI, 8701 Watertown Plank Rd., Milwaukee, WI 53226 (e-mail: prafiee{at}mcw.edu)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.